as 07-05-2024 4:00pm EST
Guardion Health Sciences Inc clinical nutrition company that develops and distributes clinically supported dietary supplements and medical foods. It offers a portfolio of science-based, clinically supported products designed to support consumers, healthcare professionals and providers, and their patients by supporting bone health, eye health, cardiovascular health, and brain health through nutrients such as Calcium, Vitamin D, Vitamin K, Carotenoids, and Omega-3s.
Founded: | 2009 | Country: | United States |
Employees: | N/A | City: | HOUSTON |
Market Cap: | 12.7M | IPO Year: | 2019 |
Target Price: | N/A | AVG Volume (30 days): | 4.7K |
Analyst Decision: | Hold | Number of Analysts: | 1 |
Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
EPS: | -4.02 | EPS Growth: | N/A |
52 Week Low/High: | $5.01 - $10.75 | Next Earning Date: | 08-12-2024 |
Revenue: | $12,062,507 | Revenue Growth: | 1.79% |
Revenue Growth (this year): | 12.01% | Revenue Growth (next year): | 10.00% |
GHSI Breaking Stock News: Dive into GHSI Ticker-Specific Updates for Smart Investing
GuruFocus.com
a month ago
Motley Fool
a month ago
CNW Group
a month ago
Energy Global
a month ago
GlobeNewswire
a month ago
Reuters
a month ago
USA TODAY
a month ago
Business Wire
a month ago
The information presented on this page, "GHSI Guardion Health Sciences Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.